JP2024515650A5 - - Google Patents
Info
- Publication number
- JP2024515650A5 JP2024515650A5 JP2023563210A JP2023563210A JP2024515650A5 JP 2024515650 A5 JP2024515650 A5 JP 2024515650A5 JP 2023563210 A JP2023563210 A JP 2023563210A JP 2023563210 A JP2023563210 A JP 2023563210A JP 2024515650 A5 JP2024515650 A5 JP 2024515650A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163176227P | 2021-04-17 | 2021-04-17 | |
| US63/176,227 | 2021-04-17 | ||
| US202163254948P | 2021-10-12 | 2021-10-12 | |
| US63/254,948 | 2021-10-12 | ||
| US202163274153P | 2021-11-01 | 2021-11-01 | |
| US63/274,153 | 2021-11-01 | ||
| US202263316568P | 2022-03-04 | 2022-03-04 | |
| US63/316,568 | 2022-03-04 | ||
| PCT/US2022/025076 WO2022221697A1 (en) | 2021-04-17 | 2022-04-15 | Lipid nanoparticle compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024515650A JP2024515650A (ja) | 2024-04-10 |
| JP2024515650A5 true JP2024515650A5 (https=) | 2025-04-21 |
| JPWO2022221697A5 JPWO2022221697A5 (https=) | 2025-04-21 |
Family
ID=81580499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563210A Pending JP2024515650A (ja) | 2021-04-17 | 2022-04-15 | 脂質ナノ粒子組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20250090471A1 (https=) |
| EP (1) | EP4322920A1 (https=) |
| JP (1) | JP2024515650A (https=) |
| KR (1) | KR20240017792A (https=) |
| AU (1) | AU2022257050A1 (https=) |
| BR (1) | BR112023021477A2 (https=) |
| CA (1) | CA3216877A1 (https=) |
| CL (1) | CL2023003077A1 (https=) |
| CO (1) | CO2023015485A2 (https=) |
| CR (1) | CR20230536A (https=) |
| IL (1) | IL307738A (https=) |
| MX (1) | MX2023012235A (https=) |
| TW (1) | TW202308597A (https=) |
| WO (1) | WO2022221697A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3234127A1 (en) * | 2021-10-08 | 2023-04-13 | Suzhou Abogen Biosciences Co., Ltd. | Lipid compounds and lipid nanoparticle compositions |
| WO2024138189A2 (en) | 2022-12-22 | 2024-06-27 | Intellia Therapeutics, Inc. | Methods for analyzing nucleic acid cargos of lipid nucleic acid assemblies |
| WO2024199282A1 (zh) * | 2023-03-28 | 2024-10-03 | 苏州艾博生物科技有限公司 | 脂质化合物和脂质纳米颗粒组合物 |
| US12311033B2 (en) | 2023-05-31 | 2025-05-27 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025049481A1 (en) * | 2023-08-28 | 2025-03-06 | Intellia Therapeutics, Inc. | Methods of editing an hla-a gene in vitro |
| WO2025049432A1 (en) * | 2023-08-28 | 2025-03-06 | Intellia Therapeutics, Inc. | Methods for editing hla-a in cells pre-screened for the absence of one or both alleles of hla-h*01 |
| WO2025064396A1 (en) | 2023-09-18 | 2025-03-27 | Intellia Therapeutics, Inc. | Nuclease resistant double stranded dna product for non-viral delivery to a cell and methods of production thereof |
| WO2025064401A1 (en) | 2023-09-18 | 2025-03-27 | Intellia Therapeutics, Inc. | Nuclease resistant single stranded dna product for non-viral delivery to a cell and methods of production thereof |
| WO2025128871A2 (en) | 2023-12-13 | 2025-06-19 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| WO2025137301A1 (en) * | 2023-12-20 | 2025-06-26 | Intellia Therapeutics, Inc. | Methods for rapid engineering of cells |
| WO2025240946A1 (en) | 2024-05-17 | 2025-11-20 | Intellia Therapeutics, Inc. | Lipid nanoparticles and lipid nanoparticle compositions |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030083272A1 (en) | 1997-09-19 | 2003-05-01 | Lahive & Cockfield, Llp | Sense mrna therapy |
| WO2006007712A1 (en) | 2004-07-19 | 2006-01-26 | Protiva Biotherapeutics, Inc. | Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents |
| WO2011076807A2 (en) | 2009-12-23 | 2011-06-30 | Novartis Ag | Lipids, lipid compositions, and methods of using them |
| WO2011091324A2 (en) | 2010-01-22 | 2011-07-28 | The Scripps Research Institute | Methods of generating zinc finger nucleases having altered activity |
| CN103668470B (zh) | 2012-09-12 | 2015-07-29 | 上海斯丹赛生物技术有限公司 | 一种dna文库及构建转录激活子样效应因子核酸酶质粒的方法 |
| WO2014093694A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes |
| DK2931898T3 (en) | 2012-12-12 | 2016-06-20 | Massachusetts Inst Technology | CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS |
| CA2895155C (en) | 2012-12-17 | 2021-07-06 | President And Fellows Of Harvard College | Rna-guided human genome engineering |
| EP3608308B1 (en) | 2013-03-08 | 2021-07-21 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| ES2895651T3 (es) | 2013-12-19 | 2022-02-22 | Novartis Ag | Lípidos y composiciones lipídicas para la administración de agentes activos |
| EP3169309B1 (en) | 2014-07-16 | 2023-05-10 | Novartis AG | Method of encapsulating a nucleic acid in a lipid nanoparticle host |
| EP4286012A3 (en) | 2015-09-17 | 2024-05-29 | ModernaTX, Inc. | Compounds and compositions for intracellular delivery of therapeutic agents |
| WO2018073393A2 (en) | 2016-10-19 | 2018-04-26 | Cellectis | Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy |
| WO2019147805A2 (en) | 2018-01-26 | 2019-08-01 | The Board Of Trustees Of The Leland Stanford Junior University | Regulatory t cells targeted with chimeric antigen receptors |
| AU2020248337A1 (en) * | 2019-03-28 | 2021-11-04 | Intellia Therapeutics, Inc. | Compositions and methods for ttr gene editing and treating ATTR amyloidosis comprising a corticosteroid or use thereof |
| WO2020219876A1 (en) | 2019-04-25 | 2020-10-29 | Intellia Therapeutics, Inc. | Ionizable amine lipids and lipid nanoparticles |
| US12569438B2 (en) * | 2019-07-29 | 2026-03-10 | Georgia Tech Research Corporation | Nanomaterials containing constrained lipids and uses thereof |
-
2022
- 2022-04-15 BR BR112023021477A patent/BR112023021477A2/pt not_active Application Discontinuation
- 2022-04-15 TW TW111114501A patent/TW202308597A/zh unknown
- 2022-04-15 IL IL307738A patent/IL307738A/en unknown
- 2022-04-15 KR KR1020237039429A patent/KR20240017792A/ko active Pending
- 2022-04-15 JP JP2023563210A patent/JP2024515650A/ja active Pending
- 2022-04-15 AU AU2022257050A patent/AU2022257050A1/en active Pending
- 2022-04-15 EP EP22721589.4A patent/EP4322920A1/en active Pending
- 2022-04-15 CR CR20230536A patent/CR20230536A/es unknown
- 2022-04-15 CA CA3216877A patent/CA3216877A1/en active Pending
- 2022-04-15 MX MX2023012235A patent/MX2023012235A/es unknown
- 2022-04-15 US US18/287,239 patent/US20250090471A1/en active Pending
- 2022-04-15 WO PCT/US2022/025076 patent/WO2022221697A1/en not_active Ceased
-
2023
- 2023-10-16 CL CL2023003077A patent/CL2023003077A1/es unknown
- 2023-11-16 CO CONC2023/0015485A patent/CO2023015485A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024515650A5 (https=) | ||
| CL2025003878A1 (es) | Sistemas de generación de energía a partir de fuentes geotérmicas y métodos de operación y construcción de los mismos. | |
| BR102023014872A2 (https=) | ||
| BR102023012440A2 (https=) | ||
| BR102023010976A2 (https=) | ||
| BR102023009641A2 (https=) | ||
| BR102023008688A2 (https=) | ||
| BR102023007252A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR202022009269U2 (https=) | ||
| BR202022005961U2 (https=) | ||
| BR202022001779U2 (https=) | ||
| BR202022000931U2 (https=) | ||
| CN307046253S (https=) | ||
| CN307048966S (https=) | ||
| BY13144U (https=) | ||
| BY13143U (https=) | ||
| BY13142U (https=) | ||
| BY13141U (https=) | ||
| CN307046901S (https=) | ||
| CN307046678S (https=) | ||
| BY13140U (https=) | ||
| CN307046593S (https=) | ||
| CN307047695S (https=) |